Showing 291-300 of 804 results for "".
CBD in the Holistic Practice of Dermatology
https://practicaldermatology.com/topics/psoriasis/cbd-in-the-holistic-practice-of-dermatology/23319/A growing body evidence suggests CBD may help with common symptoms of dermatologic diseases. Here’s what we know so far.Monitoring Biologic Therapy In Psoriasis: A Primer
https://practicaldermatology.com/topics/psoriasis/monitoring-biologic-therapy-in-psoriasis-a-primer/20931/Treatments are generally safe and well-tolerated, however, prescribers must monitor for risk factors.A.G.E. Interrupter Advanced: Newest Innovative Anti-Aging Cream
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/age-interrupter-advanced-newest-innovative-anti-aging-cream/23930/Turmeric, Curcumin, and Curcuminoids: A Dermatologic Review
https://practicaldermatology.com/columns/clinical-focus-1/turmeric-curcumin-and-curcuminoids-a-dermatologic-review/23377/Curcumin, one of the active compounds of turmeric, exhibits anti-inflammatory, antimicrobial, antioxidant, anti-nociceptive, and antineoplastic properties.The Future of Atopic Dermatitis Therapy
https://practicaldermatology.com/topics/general-topics/the-future-of-atopic-dermatitis-therapy/21143/As new research elucidates the individual mechanisms of atopic dermatitis, the development of therapies that more directly influence the disease may change the scope of treatment.Emerging Therapies in the Evolving Biologic Platform for Psoriasis Treatment
https://practicaldermatology.com/topics/practice-management/emerging-therapies-in-the-evolving-biologic-platform-for-psoriasis-treatment/21377/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20393/Investigational Oral Treatments for Psoriasis: A Review of Phase 2 and 3 Trials
https://practicaldermatology.com/topics/psoriasis/investigational-oral-treatments-for-psoriasis-a-review-of-phase-2-and-3-trials/23318/Although biologic medications have proven to be highly effective in the treatment of psoriasis, there remains a need for oral medications that offer similar success rates. Here’s a look in the pipeline.Exploring Patient-Reported Outcomes Measures in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/exploring-patient-reported-outcomes-measures-in-atopic-dermatitis/23886/Patient-reported outcomes may solve some of the challenges with measuring the physical and psychosocial manifestations.Atypical Sweet Syndrome: A Case Report and Brief Literature Review
https://practicaldermatology.com/topics/rare-disease/atypical-sweet-syndrome-a-case-report-and-brief-literature-review/23610/A case highlights the complexity of this diagnosis, including its management and workup, especially when pathology findings are atypical.